Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CT101: D-BEYOND: A window of opportunity trial evaluating denosumab, a RANK-ligand (RANKL) inhibitor and its biological effects in young pre-menopausal women diagnosed with early breast cancer

Cancer Res (2018) 78 (13_Supplement): CT101.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Jie Ming
  • Shane J. F. Cronin
  • Josef M. Penninger
Frontiers in Oncology (2020) 10
  • Maria V. Deligiorgi
  • Mihalis I. Panayiotidis
  • Dimitrios T. Trafalis
Expert Review of Clinical Pharmacology (2020) 13 (11): 1235.
  • Peter A. van Dam
  • Yannick Verhoeven
  • Julie Jacobs
  • An Wouters
  • Wiebren Tjalma
  • Filip Lardon
  • Tim Van den Wyngaert
  • Jonatan Dewulf
  • Evelien Smits
  • Cécile Colpaert
  • Hans Prenen
  • Marc Peeters
  • Martin Lammens
  • Xuan Bich Trinh
International Journal of Molecular Sciences (2019) 20 (9): 2183.
  • Elizabeth Ahern
  • Mark J. Smyth
  • William C. Dougall
  • Michele W. L. Teng
Nature Reviews Clinical Oncology (2018) 15 (11): 676.
Close Modal

or Create an Account

Close Modal
Close Modal